AASLD, American Association for the Study of Liver DiseasesAntiviral agentsHCV, hepatitis C virusIDSA, Infectious Diseases Society of AmericaLLOQ, lower limit of quantificationOpiate substitution treatmentPublic healthSVR, sustained virological response...
AASLD指南: 诊断、丙型肝炎的管理和治疗 相关内容 ait will take a long time for the government to change the migrants’ situation completely and provide them with opportunities and rights equal to those of local urban people in the areas of employment, payment, work conditions, social security, ac...
The drugs are taken once daily by mouth. The duration of treatment can run anywhere from eight to 24 weeks, depending on the genotype, stage of the infection, previous treatment history, and presence or absence of cirrhosis. On occasion, the drugribavirinmay be added to the treatment plan.2...
By the late 2000s, the standard treatment of hepatitis C infection was peginterferon with ribavirin. In 2011, the FDA approved the protease inhibitors boceprevir and telaprevir for add-on treatment to peginterferon and ribavirin to boost rates of sustained viral response. As of 2014, mo...
AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016;63(1):261-283.Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63:261-283.Terrault N, Bzowej N, Chang K-M, Hwang J, Jonas M, Murad H. AASLD ...
Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. Published online May 25, 2023. doi:10.1093/cid/ciad319 Editors' note: Artificial intelligence aided in the creation of this content. ...
In Japan, 1.5–2 million people are chronically infected with hepatitis C virus (HCV) infection. New direct-acting antiviral agents (DAA) offer an unprecedented opportunity to cure HCV. While the price of HCV treatment decreased recently in most countrie
hepatitis CguidebooksUnited States...YANG MingJournal of Clinical HepatologyJournal of Clinical HepatologyXU Ying,LIU Yu,SUN Jian.,.Key points of the AASLD's guidelines on hepatitis B diagnosis and treatment.[J];临床肝胆病杂志,2013-02XU Ying,LIU Yu,SUN Jian.,.Key points of the AASLD's ...
Recently, Spain initiated a pilot program, JAILFREE-C, to treat HCV in prisons using direct-acting antivirals (DAAs). Our aim was to identify a cost-effective strategy to scale-up HCV treatment in all prisons. Using a validated agent-based model, we simulated the HCV landscape in Spain’...
Dr. Kwo highlighted the effectiveness of HCV treatment in PWID and the need to do more to reach out to the community. Of particular note, Dr. Kwo emphasized the need to provide hepatitis C treatment for high risk populations who are able to achieve high cure rates with low rates of rela...